ONI BioPharma Licenses Unique Gene Targets for Colorectal Cancer
ALACHUA, FL--(Marketwire - September 29, 2008) - ONI BioPharma Inc. (AMEX: ONI) announced today that it has entered a Collaboration Agreement with a major international diagnostics company regarding ONI's unique biomarkers for early, middle and late stage colorectal cancer. Terms of the agreement have not been disclosed.